Pancreatic Neoplasms: all 3,311 studies
Page 22 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.
- Focused Ultrasound for the Treatment of Pancreatic Cancer - an International RegistryTerminatedNCT03724435
- Early Support in Primary Care for People Starting Treatment for CancerCompletedNCT03719716Not applicable
- Total Tumor Mapping (TTM) for Resectable Pancreatic CancerWithdrawnNCT03718650Early Phase 1
- Evaluation of Ocoxin-Viusid® in Advanced Pancreatic AdenocarcinomaCompletedNCT03717298Phase 2
- SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer PatientsTerminatedNCT03716596Phase 1
- Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular InvolvementActive, not recruitingNCT03716531Not applicable
- A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas CancerWithdrawnNCT03707444
- Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic AdenocarcinomaActive, not recruitingNCT03704662Not applicable
- Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic CancerStatus unknownNCT03703063Phase 1
- CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic CancerCompletedNCT03699319Phase 1/2
- High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic CancerWithdrawnNCT03697239Phase 1/2
- First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRICompletedNCT03693677Phase 2
- A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk GroupsCompletedNCT03693378
- Pancreatic Locally Advanced Irresectable Cancer AblationStatus unknownNCT03690323Not applicable
- CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)WithdrawnNCT03682744Phase 1
- Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid TumorsActive, not recruitingNCT03682289Phase 2
- Evaluation of CEMIP in Pancreatic CancerStatus unknownNCT03679910
- 9-ING-41 in Patients With Advanced CancersActive, not recruitingNCT03678883Phase 2
- Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic CancerStatus unknownNCT03665571
- Study of Sirolimus in Patients With Advanced Pancreatic CancerStatus unknownNCT03662412Phase 1/2
- Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic CancerStatus unknownNCT03662035Phase 2
- Pancreaticoduodenectomy in Elderly Pancreatic Ductal Adenocarcinoma PatientsCompletedNCT03659903
- Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal PancreatectomyStatus unknownNCT03659292Not applicable
- Eus-guided Cryothermal Ablation in Stage III Pancreatic AdenocarcinomaWithdrawnNCT03649035Phase 3
- Stereotactic Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer (LAPC)CompletedNCT03648632Not applicable
- Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic CancerCompletedNCT03645148Phase 1
- Study of Autologous T-cells in Patients With Metastatic Pancreatic CancerStatus unknownNCT03638193Not applicable
- Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic CancerStatus unknownNCT03636308Phase 2
- Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDACStatus unknownNCT03634332Phase 2
- Web-based Treatment Information Tool for People With Advanced Pancreatic CancerCompletedNCT03632850
- Monitoring of patIents With Microdialysis Following PancreaticoduodenectomyActive, not recruitingNCT03631173Not applicable
- BP-C1 in Short-term Treatment of Metastatic Pancreatic CancerCompletedNCT03627390Phase 2
- Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine CancersWithdrawnNCT03623984Early Phase 1
- RCT of Mobile Apps & FitBit v. Usual CareSuspendedNCT03623464Not applicable
- EUS-FNB for Solid Pancreatic Lesions: Side-fenestrated Vs Fork-tip NeedleCompletedNCT03622229Not applicable
- Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®)Status unknownNCT03621852
- Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic CancerActive, not recruitingNCT03621644Not applicable
- Gemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma.CompletedNCT03620461
- Pancreatic Cancer Dietary Assessment StudyCompletedNCT03616431
- Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) SystemCompletedNCT03614910
- Acelarin First Line Randomised Pancreatic StudySuspendedNCT03610100Phase 2/3
- A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesStatus unknownNCT03607643Phase 1/2
- Niraparib in Patients With Pancreatic CancerCompletedNCT03601923Phase 2
- Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic CancerTerminatedNCT03600623Early Phase 1
- Evaluation of GEMCITEST in Patients With Pancreatic Cancer and Treated by ChemotherapyCompletedNCT03599154
- Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOXCompletedNCT03590275
- Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic CancerTerminatedNCT03585062Phase 2
- Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic CancerActive, not recruitingNCT03572400Phase 2
- Bethanechol Prior to Pancreatic SurgeryCompletedNCT03572283Early Phase 1
- Incidence of POPF in the Resection of the Left Pancreas With RFATStatus unknownNCT03570502
- Study Comparing Pancreatic EUS-FNB With the 20-gauge Procore® and the 22-gauge Acquire® NeedlesCompletedNCT03567863Not applicable
- Early Recovery Outcomes After Standardized Fast-track Whipples ProcedureCompletedNCT03566056
- Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate CancerWithdrawnNCT03563352
- Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic CancerActive, not recruitingNCT03563248Phase 2
- QUILT-3.088: NANT Pancreatic Cancer VaccineWithdrawnNCT03563144Phase 2
- Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic TumorStatus unknownNCT03558945Phase 1
- An Expanded Access Program for AM0010 (Pegilodecakin)No longer availableNCT03554434
- Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 TrialActive, not recruitingNCT03553004Phase 2
- QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.CompletedNCT03552718Phase 1
- Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy TissuesStatus unknownNCT03544255
- A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer PatientsWithdrawnNCT03541486Phase 2
- Biological Effect of Warfarin on Pancreatic CancerWithdrawnNCT03536208Early Phase 1
- Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study)CompletedNCT03532347Not applicable
- Gene Expression in Pancreatic CancerTerminatedNCT03531125
- A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic CancerStatus unknownNCT03528785Phase 2
- Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative DiagnosisStatus unknownNCT03524677
- Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic CancerActive, not recruitingNCT03523312Phase 2
- Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic CancerTerminatedNCT03520790Phase 1
- CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic CancerCompletedNCT03517176Phase 1
- Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)CompletedNCT03513705Not applicable
- Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic CancerStatus unknownNCT03513198
- Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic CancerWithdrawnNCT03509298Phase 2
- Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic CancerStatus unknownNCT03502343Phase 2
- Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.Status unknownNCT03500068Not applicable
- Autologous CARTmeso/19 Against Pancreatic CancerStatus unknownNCT03497819Early Phase 1
- In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic CancerTerminatedNCT03492164Early Phase 1
- First-line Therapy in Metastatic PDACStatus unknownNCT03487016Phase 2
- Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsActive, not recruitingNCT03485209Phase 2
- A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic CancerTerminatedNCT03481920Early Phase 1
- Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation ProgramStatus unknownNCT03475966Not applicable
- High-dose Vitamin D3 in Pancreas CancerTerminatedNCT03472833Phase 3
- Kinetics of Microparticles Under Chemotherapy in Patients With Gastric or Pancreatic CancerTerminatedNCT03471468Not applicable
- Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic CancerStatus unknownNCT03469726Not applicable
- Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic CancerCompletedNCT03469375
- 2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line TherapyCompletedNCT03468335Phase 3
- Effects of Prehabilitation and Early Mobilization for Patients Undergoing Pancreas Surgery.CompletedNCT03466593Not applicable
- Improving REsectability in Pancreatic NEoplasms (IRENE)Status unknownNCT03460925Not applicable
- Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)Active, not recruitingNCT03460769
- A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3Status unknownNCT03457844Phase 2
- Comparison Between Volatile Anesthetic-desflurane and Total Intravenous Anesthesia With Propofol and Remifentanil on Early Recovery Quality and Long Term Prognosis of Patients Undergoing Pancreatic Cancer and Common Bile Duct Cancer SurgeryStatus unknownNCT03447691Not applicable
- Comparison of Two Endoscopic Biopsic Needles for Pancreatic TumorsCompletedNCT03444051
- Divestment for Artery-involved Pancreatic CancerStatus unknownNCT03443921Not applicable
- SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic CancerCompletedNCT03443492Phase 2
- Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic NeoplasmsStatus unknownNCT03435770Not applicable
- Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration (FNA) With Rapid On-site Evaluation (ROSE) of Cytopathology vs. EUS-guided Fine Needle Biopsy (FNB) Alone in the Diagnosis of Pancreatic Solid LesionsCompletedNCT03435588Not applicable
- Surgery Impact on Circulating Tumor DNA in Pancreatic CancerCompletedNCT03435536Not applicable
- A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic CancerStatus unknownNCT03435289Phase 1
- Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic CancerWithdrawnNCT03432676Phase 2
- A Study of ABTL0812 in Pancreatic CancerSuspendedNCT03417921Phase 1/2
- Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions.Status unknownNCT03417843Not applicable